Skip to content

Clinical trials

Phase 2 Lupus Erythematosus, Systemic trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Phase: Phase 2 Country / region: Taiwan Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20101
20112
20121
20131
20153
20162
20173
20183
20193
20202
20214
20224
20231
20242
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Active, not recruiting5
Terminated5
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb3
AbbVie2
Amgen2
Anthera Pharmaceuticals2
EMD Serono Research & Development Institute, Inc.2
Eli Lilly and Company2
Genentech, Inc.2
Janssen Research & Development, LLC2
MedImmune LLC2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic35
Autoimmune Diseases6
Connective Tissue Diseases3
Immune System Diseases3
Lupus Erythematosus, Cutaneous3
Lupus Erythematosus, Discoid2
Lupus Nephritis1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.